← FDA Drug Approvals (Drugs@FDA)

LEVOCETIRIZINE DIHYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SYNTHON BV · Approved 2010-11-26

Drug application

FDA Application #
ANDA090229
Application type
Abbreviated New Drug Application (Generic)
Brand name
LEVOCETIRIZINE DIHYDROCHLORIDE
Generic name
Levocetirizine Dihydrochloride
Active ingredients
LEVOCETIRIZINE DIHYDROCHLORIDE
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
Sponsor
SYNTHON BV
First approval
2010-11-26

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown